Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.7986
+0.0026 (0.33%)
May 7, 2025, 9:30 AM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Precision Oncology Therapies
7.00M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
7.00M